PGY2 SOT Jard Walz joins us from University of Wisconsin Health to discuss "A Head-to-head Comparison of De Novo Sirolimus or Everolimus Plus Reduced-dose Tacrolimus in Kidney Transplant Recipients: A Prospective and Randomized Trial", as well as a discussion on his unique residency experience with a CMV antiviral stewardship program